Search results
Ecstasy as a PTSD treatment gets thumbs down from FDA advisers
Market Watch· 20 hours agoIn votes taken late Tuesday, the majority of the FDA advisory panel’s members said the available...
FDA Platform Technology Designation Program aims to speed development of drugs, biological products...
JD Supra· 1 day agoFDA developed the new platform technology designation program draft guidance to fulfill its requirement under Section 506K(b) of the Federal Food, Drug, and Cosmetic Act ( ...
FDA to vote Wednesday on COVID-19 shots to target emerging variants in US for 2024-25
Detroit News· 10 hours agoA U.S. Food and Drug Administration advisory committee will meet Wednesday to recommend a COVID-19...
FDA fast tracks Quince Therapeutics’ rare ataxia drug EryDex
Pharmaceutical Technology via Yahoo Finance· 1 day agoCalifornia-based biotech Quince Therapeutics has won fast track designation from the US Food and...
MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
San Jose Mercury News· 19 hours agoThe Food and Drug Administration convened a panel of outside experts Tuesday to review the latest...
Supporters think ecstasy has potential to treat PTSD, but FDA panel rejects psychedelic drug
KABC 7 Los Angeles· 7 hours agoFederal health advisers have rejected the first-ever proposal to use MDMA as a treatment for PTSD....
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 2 days agoThe current predominant strain of COVID-19 should be a key consideration during the upcoming meeting...
FDA panel to review psychedelic drug MDMA for first time
Reuters· 1 day agoThe meeting by the agency's independent experts is the farthest that a drug based on MDMA, commonly...
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
Medical Xpress· 19 hours agoThe Food and Drug Administration convened a panel of outside experts Tuesday to review the latest...
FDA panel votes against MDMA for PTSD therapy
BBC News· 12 hours agoThe prospect of MDMA being used to treat post-traumatic stress disorder (PTSD) in the United States has hit a setback after advisers for the country's health regulator voted against therapy ...
